Active	Status	Sponsor type	Region	Phase	Filter
9 Active 0 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

9 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wirrell, Elaine
NCT06598449: Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age	Recruiting	4	12	US	fenfluramine	University of Colorado, Denver, UCB Pharma	Dravet Syndrome (DS), Children Under 2 Years	12/26	07/27
TrustTSC, NCT05323734 / 2021-003441-38: Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy	Completed	3	128	Europe, Canada, US, RoW	Ganaxalone, Placebo	Marinus Pharmaceuticals, Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals, Inc.	Tuberous Sclerosis Complex	09/24	10/24
NCT05219617 / 2022-001256-42: Investigate Efficacy and Safety of Carisbamate As Adjunctive Treatment for Seizures Associated with LGS in Children and Adults	Recruiting	3	252	Europe, US, RoW	Carisbamate	SK Life Science, Inc., SK Life Science, Inc	Seizures, Lennox Gastaut Syndrome	06/25	06/26
NCT01533506: Stiripentol in Dravet Syndrome	No Longer Available	N/A		US	stiripentol, Diacomit	Mayo Clinic	Dravet Syndrome	02/13	02/13
NCT05544058: Retrospective Non-interventional Study of Stiripentol Use in Dravet Patients in the USA	Completed	N/A	100	US	Retrospective study	Biocodex	Dravet Syndrome	06/24	06/24
Barber, Arkady
NCT05219617 / 2022-001256-42: Investigate Efficacy and Safety of Carisbamate As Adjunctive Treatment for Seizures Associated with LGS in Children and Adults	Recruiting	3	252	Europe, US, RoW	Carisbamate	SK Life Science, Inc., SK Life Science, Inc	Seizures, Lennox Gastaut Syndrome	06/25	06/26
NCT05067634 / 2020-005344-27: Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures	Recruiting	3	140	Europe, US, RoW	Xcopri	SK Life Science, Inc.	Partial Epilepsy	05/26	07/26
NCT04903314: Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects with Partial-Onset Seizures	Recruiting	1	24	Europe, US, RoW	Xcopri	SK Life Science, Inc.	Partial Epilepsy	10/25	03/26
Flasterstein, Bernardo
NCT05219617 / 2022-001256-42: Investigate Efficacy and Safety of Carisbamate As Adjunctive Treatment for Seizures Associated with LGS in Children and Adults	Recruiting	3	252	Europe, US, RoW	Carisbamate	SK Life Science, Inc., SK Life Science, Inc	Seizures, Lennox Gastaut Syndrome	06/25	06/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wirrell, Elaine
NCT06598449: Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age	Recruiting	4	12	US	fenfluramine	University of Colorado, Denver, UCB Pharma	Dravet Syndrome (DS), Children Under 2 Years	12/26	07/27
TrustTSC, NCT05323734 / 2021-003441-38: Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy	Completed	3	128	Europe, Canada, US, RoW	Ganaxalone, Placebo	Marinus Pharmaceuticals, Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals, Inc.	Tuberous Sclerosis Complex	09/24	10/24
NCT05219617 / 2022-001256-42: Investigate Efficacy and Safety of Carisbamate As Adjunctive Treatment for Seizures Associated with LGS in Children and Adults	Recruiting	3	252	Europe, US, RoW	Carisbamate	SK Life Science, Inc., SK Life Science, Inc	Seizures, Lennox Gastaut Syndrome	06/25	06/26
NCT01533506: Stiripentol in Dravet Syndrome	No Longer Available	N/A		US	stiripentol, Diacomit	Mayo Clinic	Dravet Syndrome	02/13	02/13
NCT05544058: Retrospective Non-interventional Study of Stiripentol Use in Dravet Patients in the USA	Completed	N/A	100	US	Retrospective study	Biocodex	Dravet Syndrome	06/24	06/24
Barber, Arkady
NCT05219617 / 2022-001256-42: Investigate Efficacy and Safety of Carisbamate As Adjunctive Treatment for Seizures Associated with LGS in Children and Adults	Recruiting	3	252	Europe, US, RoW	Carisbamate	SK Life Science, Inc., SK Life Science, Inc	Seizures, Lennox Gastaut Syndrome	06/25	06/26
NCT05067634 / 2020-005344-27: Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures	Recruiting	3	140	Europe, US, RoW	Xcopri	SK Life Science, Inc.	Partial Epilepsy	05/26	07/26
NCT04903314: Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects with Partial-Onset Seizures	Recruiting	1	24	Europe, US, RoW	Xcopri	SK Life Science, Inc.	Partial Epilepsy	10/25	03/26
Flasterstein, Bernardo
NCT05219617 / 2022-001256-42: Investigate Efficacy and Safety of Carisbamate As Adjunctive Treatment for Seizures Associated with LGS in Children and Adults	Recruiting	3	252	Europe, US, RoW	Carisbamate	SK Life Science, Inc., SK Life Science, Inc	Seizures, Lennox Gastaut Syndrome	06/25	06/26